OPKO Health Q1 2024 GAAP EPS $(0.12) Misses $(0.10) Estimate, Sales $173.700M Miss $182.990M Estimate
OPKO Health Q1 2024 GAAP EPS $(0.12) Misses $(0.10) Estimate, Sales $173.700M Miss $182.990M Estimate
OPKO Health 2024年第一季度GAAP每股收益（0.12）未達到預期（0.10）美元，銷售額爲1.737億美元，未達到1.8299億美元的預期
OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 20 percent. This is a 500 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $173.700 million which missed the analyst consensus estimate of $182.990 million by 5.08 percent. This is a 26.89 percent decrease over sales of $237.600 million the same period last year.
OPKO Health（納斯達克股票代碼：OPK）公佈的季度虧損爲每股0.12美元，比分析師普遍預期的0.10美元（0.10美元）低20％。這比去年同期每股虧損0.02美元（0.02）下降了500％。該公司公佈的季度銷售額爲1.737億美元，比分析師普遍預期的1.8299億美元低5.08％。這比去年同期的2.376億美元銷售額下降了26.89％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。